Biomedical Textiles Market Expected to Reach $30.3 Billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Biomedical Textiles Market," The biomedical textiles market was valued at $16.6 billion in 2022, and is estimated to reach $30.3 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032.

Biomedical textiles are specialized textiles designed for use in medical and healthcare applications. They are specifically engineered to meet the requirements of the healthcare industry, providing unique properties and functionalities to address various medical needs. Biomedical textiles play a crucial role in improving patient care, comfort, and treatment outcomes. These textiles are designed to be biocompatible, meaning they can interact with biological systems without causing harm or adverse reactions. They are often made from materials such as synthetic fibers, natural fibers, or a combination of both, depending on the desired properties and application requirements.

There is growing awareness among healthcare professionals and patients regarding the benefits of biomedical textiles. As healthcare providers recognize the advantages of using specialized textiles in wound care, surgical procedures, and other applications, the demand for these products increases, driving market growth. These factors are contributing to the growth of the biomedical textiles market during the forecast period.

However biomedical textiles, especially those with advanced functionalities and specialized properties, can be costly compared to traditional textiles. The development, manufacturing, and quality control processes involved in producing biomedical textiles contribute to their higher price. This cost factor can limit their widespread adoption, particularly in resource-constrained healthcare settings.

On the contrary, regulatory bodies enforce standards and guidelines for medical textiles to ensure their safety, efficacy, and quality. Compliance with these standards is essential for manufacturers, healthcare facilities, and end-users. The adherence to regulatory requirements drives the development of reliable and high-quality biomedical textiles in the market. These factors together are projected to create remunerative opportunities for the expansion of the biomedical textiles market during the forecast period. The biomedical textiles market is segmented on the basis of fiber type, fabric type, application, and region.

By fiber type, the market is segregated into non-biodegradable fiber, biodegradable fiber, and others. The biodegradable segment dominated the global market in terms of revenue in 2022, with 50% of the total share. This is due to the factors such as, there is an increasing demand from healthcare professionals, patients, and consumers for more sustainable and environmentally conscious products. Biodegradable fiber-based biomedical textiles can enhance the reputation and market position of healthcare providers and manufacturers by demonstrating their commitment to sustainability and eco-friendly practices. These factors are anticipated to offer most lucrative opportunities for the market.

By fabric type, the market is segregated into woven, non-woven, others. The woven segment dominated the global market in terms of revenue in 2022, with 49% of the total share. Woven fabrics have a long history of use in medical and healthcare applications, and many woven biomedical textiles have already undergone regulatory approvals and meet relevant standards. This regulatory compliance and acceptance facilitate faster adoption and integration of woven fabrics into medical devices and therapies. All these factors are creating the most remunerative opportunities for the market.

By application, the global biomedical textiles market is segmented into implantable, non-implantable, others. The implantable application dominated the global market in terms of revenue in 2022, with 53% of the total share. Biomedical textiles are used in cardiovascular implants such as stents, heart valves, and vascular grafts. Textile-based stents provide support and maintain vessel potency after angioplasty, while textile-covered heart valves and vascular grafts offer durability, biocompatibility, and improved hemodynamics.

In addition, Biomedical textiles can be engineered to incorporate drug delivery functionalities. They can be designed to release drugs or therapeutic agents over time, allowing for controlled and localized delivery to specific implant sites. This factor is expected to boost market growth during the forecast period.

Region-wise, the biomedical textiles market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America biomedical textiles market is projected to grow at the highest CAGR during the forecast period. This is attributed to the fact that, the U.S. is a leading market for surgical procedures, and biomedical textiles are extensively used in surgical drapes, gowns, sutures, and other surgical products. The demand for advanced surgical textiles that offer superior infection control, comfort, and protection drives market growth.

Furthermore, Canada emphasizes healthcare innovation, research, and development. The country has a strong presence of academic institutions, research organizations, and industry players that collaborate to develop advanced medical textiles and drive market growth.

Key players operating in the global biomedical textiles market include Swicofil AG, DSM, CORTLAND BIOMEDICAL, Poly-Med Incorporated, Bally Ribbon Mills, ATEX Technologies, Integra Life Sciences Corporation, Medline Industries Inc., and B. Braun Melsungen AG.

Key Findings: 

• On the basis of fiber type, the biodegradable segment is expected to grow at a CAGR of 6.4%, in terms of revenue, during the forecast period.
• On the basis of fabric type, the woven segment is expected to grow at a CAGR of 6.1%, in terms of revenue, during the forecast period.
• Depending on application, the implantable segment is expected to grow at a CAGR of 6.1%, in terms of revenue, during the forecast period.
• Region wise, North America garnered a share of 33% in 2022.
• Asia-Pacific garnered around 30% share in 2022.